chr17-41819306-TC-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_021939.4(FKBP10):c.831delC(p.Gly278AlafsTer20) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,172 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P277P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021939.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bruck syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- osteogenesis imperfecta type 11Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Illumina
- osteogenesis imperfecta type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- osteogenesis imperfecta type 4Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arthrogryposis-like syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Bruck syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKBP10 | NM_021939.4 | c.831delC | p.Gly278AlafsTer20 | frameshift_variant | Exon 5 of 10 | ENST00000321562.9 | NP_068758.3 | |
FKBP10 | XM_011525099.4 | c.831delC | p.Gly278AlafsTer20 | frameshift_variant | Exon 5 of 11 | XP_011523401.1 | ||
FKBP10 | XM_011525100.3 | c.558delC | p.Gly187AlafsTer20 | frameshift_variant | Exon 4 of 10 | XP_011523402.1 | ||
FKBP10 | XM_047436515.1 | c.558delC | p.Gly187AlafsTer20 | frameshift_variant | Exon 4 of 9 | XP_047292471.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151468Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000400 AC: 1AN: 250308 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461704Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727140 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151468Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73918 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Gly278Alafs*20) in the FKBP10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FKBP10 are known to be pathogenic (PMID: 22689593, 22949511). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta (PMID: 28492130). ClinVar contains an entry for this variant (Variation ID: 503914). For these reasons, this variant has been classified as Pathogenic. -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28492130, 34335676, 29512769, 30993005, 32770541) -
Osteogenesis imperfecta type 11 Pathogenic:1
The FKBP10 c.831delC (p.Gly278AlafsTer20) variant results in a frameshift and is predicted to result in a premature truncation of the protein. The p.Gly278AlafsTer20 variant has been reported in a compound heterozygous state in eight individuals with osteogenesis imperfecta, including in three siblings and in at least three different families, and in a heterozygous state in one healthy parent of an affected individual (Vorster et al. 2017; Zhang et al. 2018; Chetty et al. 2019). In the seven individuals reported by Voster et al. (2017) and Chetty et al. (2019), all of whom were from southern Africa, the p.Gly278AlafsTer20 variant was identified in trans with another frameshift variant that occurs at the same nucleotide position, c.831dupC (p.Gly278ArgfsTer95), a pathogenic variant that Voster et al. (2017) suggest to be a founder variant in black southern African populations. In the remaining case, a male of Chinese heritage, the p.Gly278AlafsTer20 variant was found in trans with a different frameshift variant (Zhang et al. 2018). Control data are unavailable for this variant, which is reported at a frequency of 0.000081 in the African population of the Genome Aggregation Database. Chetty et al. (2019) indicate that the p.Gly278AlafsTer20 variant results in the loss of two peptidylprolyl isomerase domains and two EF-hand domains, which are important for appropriate protein localization. Based on the available evidence, the c.831delC (p.Gly278AlafsTer20) variant is classified as pathogenic for osteogenesis imperfecta with or without joint contractures. -
Bruck syndrome 1;C3151218:Osteogenesis imperfecta type 11 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at